Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.


TSX:TH - Post by User

Comment by qwerty22on Dec 21, 2021 1:23pm
60 Views
Post# 34251188

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Omicron

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Omicron

Covid will not be eradicated. It's a false expectation. It's now endemic. It spreads among vaccinated and unvaccinated. Smallpox and polio are the wrong comparators. Influenza is probably better. You have voluntary vaccine programs aimed at the vulnerable to mitigated the effect of the disease. You can have an initial round of population wide vaccination to raise the populations immunity. The aim is not to eradicated the aim is to mitigate the worst effects.

There is a zero Covid mentality, fuelled by fear, driving politicians and the public down authoritarian paths. The data doesn't actually support that approach. Containment and mitigation should be to honest goals of policy, that doesn't require demonizing a section of the population, it also doesn't require lockdown. Reports suggest with the new omicron wave that people are choosing to be cautious, my personal experience is that we as a family are taking that route in order to save Christmas. Encouragement of that would be sufficient. 


jfm1330 wrote: This is totally false. Vaccine is not strictly for individual benefit, it is a weapon to stop a contagious disease from spreading and harming others. You take the vaccine to protect yourself, but also others. Smallpox was eradicated through mandatory vaccination. In the case of covid, governments are lacking courage to impose it because it is not deadly enough. Yes, it is crazy to say that, but in the US more than 800,000 deaths is not enough.

No man is an island, and you cannot benefit from the society without giving back to it when needed, especially in exceptionnal circumstances like this covid pandemic. The vaccine is safe and effective, it should be mandatory. I am not talking about forcing people physically to have it, but there should be significant fines imposed to those refusing to take it.

https://www.history.com/news/smallpox-vaccine-supreme-court



 

gamakichi wrote:

 The entire point of the vaccine is to save you from potential negative outcomes. 





<< Previous
Bullboard Posts
Next >>

USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse